Briggs Advisory Group’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$322K Sell
3,130
-90
-3% -$9.7K 0.18% 50
2023
Q2
$372K Buy
3,220
+176
+6% +$20K 0.21% 44
2023
Q1
$324K Buy
3,044
+27
+0.9% +$2.92K 0.19% 50
2022
Q4
$335K Buy
+3,017
New +$308K 0.21% 48
2022
Q3
Sell
-4,009
Closed -$366K 51
2022
Q2
$366K Buy
+4,009
New +$355K 0.27% 41

Other funds holding MRK

Briggs Advisory Group's MRK Position: Q3 2023 in Review

Briggs Advisory Group reduced its Merck (MRK) stake by 2.8% in Q3 2023, selling an estimated $9.7K and leaving 3,130 shares worth $322K. The position accounts for 0.18% of the portfolio, ranked #50.

Briggs Advisory Group first reported a position in MRK in Q2 2022 and has held it in 5 quarters since. The position peaked at $372K in Q2 2023. 3,213 funds tracked by Wall St. Rank hold MRK as of Q3 2023.

  • Briggs Advisory Group held 3,130 shares of Merck worth $322K as of Q3 2023.
  • Briggs Advisory Group sold 90 Merck shares in Q3 2023, an estimated $9.7K.
  • Merck made up 0.18% of Briggs Advisory Group's portfolio in Q3 2023, its #50 holding.
  • Briggs Advisory Group first reported a position in Merck in Q2 2022 and has held it in 5 quarters since.
  • Briggs Advisory Group's Merck position peaked at $372K in Q2 2023.
  • 3,213 funds tracked by Wall St. Rank held Merck as of Q3 2023.

Based on Briggs Advisory Group's 13F filing for Q3 2023, filed 27 Oct 2023.